Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001933414-24-000022
Filing Date
2024-05-23
Accepted
2024-05-23 16:22:16
Documents
1
Period of Report
2024-05-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1716495708.html 4  
1 FORM 4 wk-form4_1716495708.xml 4 3988
  Complete submission text file 0001933414-24-000022.txt   5447
Mailing Address 3 TIMES SQAURE, 12TH FLOOR NEW YORK NY 10036
Business Address
SBLENDORIO GLENN (Reporting) CIK: 0001277478 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41614 | Film No.: 24978598

Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Issuer) CIK: 0001933414 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)